SG11201605550QA - Rna-guided gene drives - Google Patents
Rna-guided gene drivesInfo
- Publication number
- SG11201605550QA SG11201605550QA SG11201605550QA SG11201605550QA SG11201605550QA SG 11201605550Q A SG11201605550Q A SG 11201605550QA SG 11201605550Q A SG11201605550Q A SG 11201605550QA SG 11201605550Q A SG11201605550Q A SG 11201605550QA SG 11201605550Q A SG11201605550Q A SG 11201605550QA
- Authority
- SG
- Singapore
- Prior art keywords
- rna
- gene drives
- guided gene
- guided
- drives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461924735P | 2014-01-08 | 2014-01-08 | |
US201462024642P | 2014-07-15 | 2014-07-15 | |
PCT/US2015/010550 WO2015105928A1 (en) | 2014-01-08 | 2015-01-08 | Rna-guided gene drives |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201605550QA true SG11201605550QA (en) | 2016-08-30 |
Family
ID=53524319
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201605550QA SG11201605550QA (en) | 2014-01-08 | 2015-01-08 | Rna-guided gene drives |
SG10201805815YA SG10201805815YA (en) | 2014-01-08 | 2015-01-08 | Rna-guided gene drives |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201805815YA SG10201805815YA (en) | 2014-01-08 | 2015-01-08 | Rna-guided gene drives |
Country Status (10)
Country | Link |
---|---|
US (1) | US10526618B2 (ja) |
EP (1) | EP3092310B1 (ja) |
JP (2) | JP6747974B2 (ja) |
CN (1) | CN106133141B (ja) |
AU (2) | AU2015204784B2 (ja) |
BR (1) | BR112016015958A2 (ja) |
CA (1) | CA2936312A1 (ja) |
SG (2) | SG11201605550QA (ja) |
WO (1) | WO2015105928A1 (ja) |
ZA (1) | ZA201604874B (ja) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
KR20220139433A (ko) | 2012-12-17 | 2022-10-14 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Rna-가이드된 인간 게놈 조작 |
AU2014207618A1 (en) | 2013-01-16 | 2015-08-06 | Emory University | Cas9-nucleic acid complexes and uses related thereto |
SG11201508028QA (en) | 2013-04-16 | 2015-10-29 | Regeneron Pharma | Targeted modification of rat genome |
US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
AU2014346559B2 (en) | 2013-11-07 | 2020-07-09 | Editas Medicine,Inc. | CRISPR-related methods and compositions with governing gRNAs |
SG10201700961TA (en) | 2013-12-11 | 2017-04-27 | Regeneron Pharma | Methods and compositions for the targeted modification of a genome |
US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
EP3161128B1 (en) | 2014-06-26 | 2018-09-26 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for targeted genetic modifications and methods of use |
US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
WO2016073559A1 (en) * | 2014-11-05 | 2016-05-12 | The Regents Of The University Of California | Methods for autocatalytic genome editing and neutralizing autocatalytic genome editing |
KR20230070319A (ko) | 2014-11-21 | 2023-05-22 | 리제너론 파마슈티칼스 인코포레이티드 | 쌍 형성된 가이드 rna를 사용하는 표적화된 유전자 변형을 위한 방법 및 조성물 |
CA2970370A1 (en) | 2014-12-24 | 2016-06-30 | Massachusetts Institute Of Technology | Crispr having or associated with destabilization domains |
US10117911B2 (en) | 2015-05-29 | 2018-11-06 | Agenovir Corporation | Compositions and methods to treat herpes simplex virus infections |
CA3012607A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Crispr enzymes and systems |
US20190175762A1 (en) * | 2015-10-02 | 2019-06-13 | President And Fellows Of Harvard College | Dependent Component Genome Editing Gene Drives |
WO2017058888A1 (en) * | 2015-10-02 | 2017-04-06 | Agenovir Corporation | Transgenic nuclease systems and methods |
US20190225955A1 (en) | 2015-10-23 | 2019-07-25 | President And Fellows Of Harvard College | Evolved cas9 proteins for gene editing |
WO2017196768A1 (en) * | 2016-05-09 | 2017-11-16 | President And Fellows Of Harvard College | Self-targeting guide rnas in crispr system |
WO2017196858A1 (en) * | 2016-05-09 | 2017-11-16 | Massachusetts Institute Of Technology | Methods to design and use gene drives |
IL308426A (en) | 2016-08-03 | 2024-01-01 | Harvard College | Adenosine nuclear base editors and their uses |
CA3033327A1 (en) | 2016-08-09 | 2018-02-15 | President And Fellows Of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
WO2018035300A1 (en) * | 2016-08-17 | 2018-02-22 | The Regents Of The University Of California | Split trans-complementing gene-drive system for suppressing aedes aegypti mosquitos |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
EP3510154A2 (en) * | 2016-09-09 | 2019-07-17 | Massachusetts Institute of Technology | Methods and compounds for gene insertion into repeated chromosome regions for multi-locus assortment and daisyfield drives |
KR102026421B1 (ko) * | 2016-09-13 | 2019-09-27 | 주식회사 툴젠 | 시토신 디아미나제에 의한 dna에서의 염기 교정 확인 방법 |
WO2018071868A1 (en) | 2016-10-14 | 2018-04-19 | President And Fellows Of Harvard College | Aav delivery of nucleobase editors |
WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
TW201839136A (zh) | 2017-02-06 | 2018-11-01 | 瑞士商諾華公司 | 治療血色素異常症之組合物及方法 |
EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
SG11201908658TA (en) | 2017-03-23 | 2019-10-30 | Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
CA3058584A1 (en) | 2017-03-30 | 2018-10-04 | Kyoto University | Method for inducing exon skipping by genome editing |
WO2018127611A1 (en) * | 2017-04-06 | 2018-07-12 | Dsm Ip Assets B.V. | Self-guiding integration construct (sgic) |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
WO2019139645A2 (en) | 2017-08-30 | 2019-07-18 | President And Fellows Of Harvard College | High efficiency base editors comprising gam |
WO2019067011A1 (en) * | 2017-09-29 | 2019-04-04 | Kansas State University Research Foundation | PROGRAMMED MODULATION OF CRISPR / CAS9 ACTIVITY |
AU2018352592A1 (en) | 2017-10-16 | 2020-06-04 | Beam Therapeutics, Inc. | Uses of adenosine base editors |
EP3713406A4 (en) * | 2017-11-21 | 2021-07-28 | The Regents Of The University Of California | SEXAGE AND ENDONUCLEASIC STERILIZATION IN INSECTS |
CN108285892A (zh) * | 2018-02-01 | 2018-07-17 | 上海市东方医院 | 一种稳定产生人内源性Ito,s电流的细胞模型及构建方法与应用 |
US20210222150A1 (en) * | 2018-05-29 | 2021-07-22 | Buck Institute For Research On Aging | Gene-drive in dna viruses |
GB201810253D0 (en) * | 2018-06-22 | 2018-08-08 | Imperial Innovations Ltd | Gene drive |
MA52107B1 (fr) | 2018-07-18 | 2022-11-30 | Plantarcbio Ltd | Compositions et procédés pour l'atténuation d'une infestation par le ravageur rhynchophorus ferrugineus |
WO2020041380A1 (en) | 2018-08-20 | 2020-02-27 | The Broad Institute, Inc. | Methods and compositions for optochemical control of crispr-cas9 |
WO2020041384A1 (en) | 2018-08-20 | 2020-02-27 | The Broad Institute, Inc. | 3-phenyl-2-cyano-azetidine derivatives, inhibitors of rna-guided nuclease activity |
WO2020068304A2 (en) | 2018-08-20 | 2020-04-02 | The Broad Institute, Inc. | Inhibitors of rna-guided nuclease target binding and uses thereof |
US20210324357A1 (en) | 2018-08-20 | 2021-10-21 | The Brigham And Women's Hospital, Inc. | Degradation domain modifications for spatio-temporal control of rna-guided nucleases |
WO2020191246A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
GB201906203D0 (en) * | 2019-05-02 | 2019-06-19 | Pirbright Inst | Method |
WO2021050974A1 (en) | 2019-09-12 | 2021-03-18 | The Broad Institute, Inc. | Engineered adeno-associated virus capsids |
MX2022014008A (es) | 2020-05-08 | 2023-02-09 | Broad Inst Inc | Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo. |
WO2023064706A1 (en) * | 2021-10-12 | 2023-04-20 | The Regents Of The University Of California | Gene drive system and method of use thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0126251D0 (en) * | 2001-11-01 | 2002-01-02 | Imp College Innovations Ltd | Methods |
US20120315670A1 (en) * | 2009-11-02 | 2012-12-13 | Gen9, Inc. | Compositions and Methods for the Regulation of Multiple Genes of Interest in a Cell |
NZ630900A (en) * | 2012-02-24 | 2016-10-28 | Hutchinson Fred Cancer Res | Compositions and methods for the treatment of hemoglobinopathies |
GB2500113A (en) * | 2012-03-05 | 2013-09-11 | Oxitec Ltd | Arthropod male germline gene expression system |
WO2013141680A1 (en) * | 2012-03-20 | 2013-09-26 | Vilnius University | RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX |
CA2871524C (en) * | 2012-05-07 | 2021-07-27 | Sangamo Biosciences, Inc. | Methods and compositions for nuclease-mediated targeted integration of transgenes |
DK3241902T3 (en) * | 2012-05-25 | 2018-05-07 | Univ California | METHODS AND COMPOSITIONS FOR RNA DIRECTIVE TARGET DNA MODIFICATION AND FOR RNA DIRECTIVE MODULATION OF TRANSCRIPTION |
US9688971B2 (en) * | 2012-06-15 | 2017-06-27 | The Regents Of The University Of California | Endoribonuclease and methods of use thereof |
EP2861737B1 (en) * | 2012-06-19 | 2019-04-17 | Regents Of The University Of Minnesota | Gene targeting in plants using dna viruses |
SG10201700961TA (en) * | 2013-12-11 | 2017-04-27 | Regeneron Pharma | Methods and compositions for the targeted modification of a genome |
-
2015
- 2015-01-08 WO PCT/US2015/010550 patent/WO2015105928A1/en active Application Filing
- 2015-01-08 CA CA2936312A patent/CA2936312A1/en not_active Abandoned
- 2015-01-08 CN CN201580012610.6A patent/CN106133141B/zh active Active
- 2015-01-08 SG SG11201605550QA patent/SG11201605550QA/en unknown
- 2015-01-08 EP EP15735409.3A patent/EP3092310B1/en active Active
- 2015-01-08 JP JP2016545854A patent/JP6747974B2/ja active Active
- 2015-01-08 SG SG10201805815YA patent/SG10201805815YA/en unknown
- 2015-01-08 BR BR112016015958A patent/BR112016015958A2/pt active IP Right Grant
- 2015-01-08 AU AU2015204784A patent/AU2015204784B2/en active Active
-
2016
- 2016-06-03 US US15/172,645 patent/US10526618B2/en active Active
- 2016-07-14 ZA ZA2016/04874A patent/ZA201604874B/en unknown
-
2020
- 2020-08-06 JP JP2020134219A patent/JP7187508B2/ja active Active
-
2021
- 2021-04-27 AU AU2021202590A patent/AU2021202590A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP7187508B2 (ja) | 2022-12-12 |
JP6747974B2 (ja) | 2020-08-26 |
WO2015105928A9 (en) | 2015-09-24 |
CA2936312A1 (en) | 2015-07-16 |
WO2015105928A1 (en) | 2015-07-16 |
CN106133141B (zh) | 2021-08-20 |
JP2021003112A (ja) | 2021-01-14 |
EP3092310A1 (en) | 2016-11-16 |
JP2017511685A (ja) | 2017-04-27 |
US10526618B2 (en) | 2020-01-07 |
AU2015204784A1 (en) | 2016-07-21 |
EP3092310B1 (en) | 2019-12-25 |
BR112016015958A2 (pt) | 2017-09-19 |
EP3092310A4 (en) | 2017-11-22 |
AU2021202590A1 (en) | 2021-05-27 |
CN106133141A (zh) | 2016-11-16 |
AU2015204784B2 (en) | 2021-01-28 |
US20160333376A1 (en) | 2016-11-17 |
ZA201604874B (en) | 2022-08-31 |
SG10201805815YA (en) | 2018-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201604874B (en) | Rna-guided gene drives | |
HK1245323A1 (zh) | 培養基 | |
IL251468A0 (en) | aav-based gene therapy | |
IL284577A (en) | Garden healing | |
GB201421094D0 (en) | Culture medium | |
GB201517022D0 (en) | No details | |
GB201410907D0 (en) | No details | |
GB201519531D0 (en) | No details | |
GB201517404D0 (en) | No details | |
GB201418217D0 (en) | No details | |
EP3160478A4 (en) | Optimized factor ix gene | |
GB201418216D0 (en) | No details | |
GB201407322D0 (en) | Gene therapy | |
GB201517412D0 (en) | No details | |
GB201516796D0 (en) | No details | |
IL249254A0 (en) | Gene expression system | |
GB201517574D0 (en) | No details | |
IL257500A (en) | Altered cullin1 gene | |
PT3126521T (pt) | Gene de fusão hnf4g-rspo2 | |
SG11201702844VA (en) | Photobioreactor | |
GB201517605D0 (en) | No details | |
GB201406544D0 (en) | Drive arrangement | |
GB201410910D0 (en) | No details | |
GB201801971D0 (en) | No details | |
GB201608944D0 (en) | Gene Tharapy |